A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma
A partir d'une revue de la littérature (22 études), cette méta-analyse évalue l'association entre l'indice de masse corporelle et le risque d'adénocarcinome de l'œsophage et du cardia
Background The incidence rates of esophageal and gastric cardia adenocarcinoma (EGCA) have increased over recent years in several countries, and overweight/obesity has been suggested to play a major role in these trends. In fact, higher body mass index (BMI) has been positively associated with EGCA in several studies.Material and methods We conducted a meta-analysis of case–control and cohort studies on the BMI and EGCA updated to March 2011. We estimated overall relative risks (RRs) and 95% confidence intervals (CI) for BMI between 25 and 30 and BMI ≥ 30 kg/m2, when compared with normo-weight subjects, using random-effects models.Results We identified 22 studies, including almost 8000 EGCA cases. The overall RR was 1.71 (95% CI 1.50–1.96) for BMI between 25 and 30, and was 2.34 (95% CI 1.95–2.81) for BMI ≥ 30 kg/m2. The continuous RR for an increment of 5 kg/m2 of BMI was 1.11 (95% CI 1.09–1.14). The association was stronger for esophageal adenocarcinoma (RR for BMI ≥ 30 kg/m2 = 2.73, 95% CI 2.16–3.46) than for gastric cardia adenocarcinoma (RR for BMI ≥ 30 kg/m2 = 1.93, 95% CI 1.52–2.45). No substantial differences emerged across strata of sex and geographic areas.Conclusion Overweight and obesity are strongly related to EGCA, particularly to espophageal adenocarcinoma.
Annals of Oncology 2012